Literature DB >> 25979637

Executive dysfunction in patients with transient ischemic attack and minor stroke.

Peter Sörös1, Michael Harnadek2, Treena Blake2, Vladimir Hachinski1, Richard Chan3.   

Abstract

BACKGROUND AND
OBJECTIVE: A considerable number of patients with transient ischemic attack suffer from cognitive impairment, even after recovery of focal neurological deficits. In particular, executive functions such as working memory, abstraction, reasoning, verbal fluency and cognitive flexibility are impaired in these patients. The purpose of the present study was to explore the nature and prevalence of cognitive impairment in a series of patients with transient ischemic attack and minor stroke.
MATERIALS AND METHODS: We included 140 patients (61% women) who presented with a focal cerebral ischemic event lasting less than 24h in the Urgent TIA outpatient clinic. All patients underwent a brief battery of neuropsychological tests, consisting of the Mini Mental State Examination (MMSE), Neurobehavioral Cognitive Status Examination-Judgment Subtest, Clock Drawing Test and Trail Making Test.
RESULTS: A majority of patients (57%) were impaired on one or more of these neuropsychological tests. Nearly one-third of individuals were impaired on two or more tests. Cognitive impairment was most frequently observed on the Trail Making Test Part A (31% of patients) and Part B (40%). The Trail Making Test examines executive functions, as it requires cognitive flexibility, ability to maintain a complex response set and speed of processing. By contrast, only 5% of patients were impaired on the MMSE, a widely used neuropsychological test insensitive to executive dysfunction.
CONCLUSIONS: Our results highlight the limitations of the MMSE as an independent cognitive screening instrument for patients with TIAs and minor stroke and the high prevalence of executive dysfunction in these patients.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Cognitive impairment; Executive function; Mini Mental State Examination; Stroke; Trail Making Test; Transient ischemic attack

Mesh:

Year:  2015        PMID: 25979637     DOI: 10.1016/j.jns.2015.04.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Leukoaraiosis is Associated with Worse Short-Term Functional and Cognitive Recovery after Minor Stroke.

Authors:  Zheng Zhang; Wenwei Ren; Bei Shao; Huiqin Xu; Jianhua Cheng; Qiongzhang Wang; Yingying Gu; Beilei Zhu; Jincai He
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-02-10       Impact factor: 1.742

2.  Small Vessel Disease on Neuroimaging in a 75-Year-Old Cohort (PIVUS): Comparison With Cognitive and Executive Tests.

Authors:  Ruta Nylander; Lena Kilander; Håkan Ahlström; Lars Lind; Elna-Marie Larsson
Journal:  Front Aging Neurosci       Date:  2018-07-16       Impact factor: 5.750

3.  The awareness of healthcare staff towards post-stroke cognitive impairment: a cross sectional study.

Authors:  Obaid Almalki; Mansour Abdullah Alshehri; Ahmed Mohamed El-Sodany; Amir Abdel-Raouf El-Fiky
Journal:  J Phys Ther Sci       Date:  2018-06-12

4.  Can the stroke impact scale 3.0 detect cognitive impairments in patients with a recent stroke?

Authors:  Obaid Almalki; Mansour Abdullah Alshehri; Amir Abdel-Raouf El-Fiky; Ashraf Am Abdelaal; Jamal Hs Alzaidi; Wesam Saleh A Al Attar; Fatma A Hegazy
Journal:  J Phys Ther Sci       Date:  2019-07-09

5.  Patient perspectives on health-related behavior change after transient ischemic attack or ischemic stroke.

Authors:  Dorien Brouwer-Goossensen; Heleen M den Hertog; Marinke A Mastenbroek-de Jong; Lisette J E W C van Gemert-Pijnen; Erik Taal
Journal:  Brain Behav       Date:  2021-03-04       Impact factor: 2.708

6.  Effects of N-Pep-12 dietary supplementation on neurorecovery after ischemic stroke.

Authors:  Maria Balea; Codruta Birle; Cezara Costin; Julia Marton; Ioana Anamaria Muresanu; Nicoleta Jemna; Livia Livint Popa; Dana Slavoaca; Olivia Verisezan Rosu; Adina Stan; Vitalie Vacaras; Stefan Strilciuc; Dafin F Muresanu
Journal:  Neurol Sci       Date:  2020-10-02       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.